{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:53:50Z","timestamp":1790679230272,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.cca.2017.08.017","type":"journal-article","created":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T20:01:27Z","timestamp":1503604887000},"page":"88-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Clinical, biochemical and molecular features of Iranian families with mucopolysaccharidosis: A case series"],"prefix":"10.1016","volume":"474","author":[{"given":"Vahid Reza","family":"Yassaee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9996-9406","authenticated-orcid":false,"given":"Feyzollah","family":"Hashemi-Gorji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Miryounesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Rezayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Ravesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fakhrolmolouk","family":"Yassaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadab","family":"Salehpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2017.08.017_bb0005","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2147\/OPTH.S78368","article-title":"Ocular manifestations and management recommendations of lysosomal storage disorders I: mucopolysaccharidoses","volume":"9","author":"Fenzl","year":"2015","journal-title":"Clin. Ophthalmol."},{"issue":"6","key":"10.1016\/j.cca.2017.08.017_bb0010","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/pde.12971","article-title":"Cutaneous manifestations of mucopolysaccharidoses","volume":"33","author":"Tran","year":"2016","journal-title":"Pediatr. Dermatol."},{"issue":"Suppl. 1","key":"10.1016\/j.cca.2017.08.017_bb0015","article-title":"Genetic aspects of mucopolysaccharidoses","volume":"21","author":"Lacombe","year":"2014","journal-title":"Arch. Pediatr."},{"issue":"1-2","key":"10.1016\/j.cca.2017.08.017_bb0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ymgme.2013.06.007","article-title":"Newborn screening and diagnosis of mucopolysaccharidoses","volume":"110","author":"Tomatsu","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl. 5","key":"10.1016\/j.cca.2017.08.017_bb0025","doi-asserted-by":"crossref","first-page":"v4","DOI":"10.1093\/rheumatology\/ker394","article-title":"Overview of the mucopolysaccharidoses","volume":"50","author":"Muenzer","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.cca.2017.08.017_bb0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s11689-015-9126-5","article-title":"Actigraphic investigation of circadian rhythm functioning and activity levels in children with mucopolysaccharidosis type III (Sanfilippo syndrome)","volume":"7","author":"Mumford","year":"2015","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.cca.2017.08.017_bb0035","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2147\/TACG.S57672","article-title":"Sanfilippo syndrome: causes, consequences, and treatments","volume":"8","author":"Fedele","year":"2015","journal-title":"Appl. Clin. Genet."},{"issue":"3","key":"10.1016\/j.cca.2017.08.017_bb0040","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/ped.12636","article-title":"Sanfilippo syndrome: overall review","volume":"57","author":"Andrade","year":"2015","journal-title":"Pediatr. Int."},{"issue":"2","key":"10.1016\/j.cca.2017.08.017_bb0045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ymgme.2013.11.014","article-title":"Neurocognitive and neuropsychiatric phenotypes associated with the mutation L238Q of the alpha-l-iduronidase gene in Hurler-Scheie syndrome","volume":"111","author":"Ahmed","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cca.2017.08.017_bb0050","series-title":"GeneReviews\u00ae, Seattle (WA)","article-title":"Mucopolysaccharidosis type I","author":"Clarke","year":"1993"},{"key":"10.1016\/j.cca.2017.08.017_bb0055","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jpeds.2016.11.036","article-title":"Mucopolysaccharidosis type I newborn screening: best practices for diagnosis and management","volume":"182","author":"Clarke","year":"2017","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.cca.2017.08.017_bb0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10545-016-9981-6","article-title":"Newborn screening for mucopolysaccharidoses: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometry","volume":"40","author":"Kubaski","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.cca.2017.08.017_bb0065","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ymgme.2013.05.016","article-title":"Residual alpha-l-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients","volume":"109","author":"Oussoren","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"10","key":"10.1016\/j.cca.2017.08.017_bb0070","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/gim.2014.25","article-title":"The natural history of MPS I: global perspectives from the MPS I Registry","volume":"16","author":"Beck","year":"2014","journal-title":"Genet. Med."},{"issue":"11","key":"10.1016\/j.cca.2017.08.017_bb0075","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nchembio.1357","article-title":"Insights into mucopolysaccharidosis I from the structure and action of alpha-l-iduronidase","volume":"9","author":"Bie","year":"2013","journal-title":"Nat Chem Biol"},{"issue":"2","key":"10.1016\/j.cca.2017.08.017_bb0080","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ymgme.2013.10.005","article-title":"Structural and clinical implications of amino acid substitutions in alpha-l-iduronidase: insight into the basis of mucopolysaccharidosis type I","volume":"111","author":"Saito","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"36","key":"10.1016\/j.cca.2017.08.017_bb0085","doi-asserted-by":"crossref","first-page":"14628","DOI":"10.1073\/pnas.1306939110","article-title":"Human alpha-L-iduronidase uses its own N-glycan as a substrate-binding and catalytic module","volume":"110","author":"Maita","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.cca.2017.08.017_bb0090","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10545-010-9199-y","article-title":"Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype","volume":"33","author":"Valstar","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.cca.2017.08.017_bb0095","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ymgme.2010.01.004","article-title":"Identification and characterization of a novel homozygous deletion in the alpha-N-acetylglucosaminidase gene in a patient with Sanfilippo type B syndrome (mucopolysaccharidosis IIIB)","volume":"100","author":"Champion","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cca.2017.08.017_bb0100","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ymgmr.2014.08.006","article-title":"Identification of 17 novel mutations in 40 Argentinean unrelated families with mucopolysaccharidosis type II (Hunter syndrome)","volume":"1","author":"Amartino","year":"2014","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"3","key":"10.1016\/j.cca.2017.08.017_bb0105","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ymgme.2016.05.003","article-title":"Molecular diagnosis of 65 families with mucopolysaccharidosis type II (Hunter syndrome) characterized by 16 novel mutations in the IDS gene: Genetic, pathological, and structural studies on iduronate-2-sulfatase","volume":"118","author":"Kosuga","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.cca.2017.08.017_bb0110","first-page":"1202","article-title":"Mucopolysaccharidosis type II (Hunter syndrome): mutation \u201chot spots\u201d in the iduronate-2-sulfatase gene","volume":"59","author":"Rathmann","year":"1996","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.cca.2017.08.017_bb0115","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10545-012-9533-7","article-title":"Molecular characterization of 355 mucopolysaccharidosis patients reveals 104 novel mutations","volume":"36","author":"Pollard","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.cca.2017.08.017_bb0120","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s004390050901","article-title":"Mutational spectrum of the iduronate-2-sulfatase (IDS) gene in 36 unrelated Russian MPS II patients","volume":"103","author":"Karsten","year":"1998","journal-title":"Hum. Genet."},{"issue":"6","key":"10.1016\/j.cca.2017.08.017_bb0125","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/(SICI)1098-1004(1997)10:6<479::AID-HUMU10>3.0.CO;2-X","article-title":"Identification of 16 sulfamidase gene mutations including the common R74C in patients with mucopolysaccharidosis type IIIA (Sanfilippo A)","volume":"10","author":"Bunge","year":"1997","journal-title":"Hum. Mutat."},{"issue":"1","key":"10.1016\/j.cca.2017.08.017_bb0130","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ajmg.a.33779","article-title":"Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece","volume":"155A","author":"Heron","year":"2011","journal-title":"Am. J. Med. Genet. A"},{"issue":"Pt 5","key":"10.1016\/j.cca.2017.08.017_bb0135","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1107\/S1399004714002739","article-title":"Structure of sulfamidase provides insight into the molecular pathology of mucopolysaccharidosis IIIA","volume":"70","author":"Sidhu","year":"2014","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"Pt 6","key":"10.1016\/j.cca.2017.08.017_bb0140","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/brain\/awv074","article-title":"Adult-onset painful axonal polyneuropathy caused by a dominant NAGLU mutation","volume":"138","author":"Tetreault","year":"2015","journal-title":"Brain"},{"issue":"7367","key":"10.1016\/j.cca.2017.08.017_bb0145","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature10423","article-title":"Deep sequencing reveals 50 novel genes for recessive cognitive disorders","volume":"478","author":"Najmabadi","year":"2011","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cca.2017.08.017_bb0150","doi-asserted-by":"crossref","DOI":"10.1136\/jmg.39.2.e3","article-title":"Identification and characterisation of mutations underlying Sanfilippo syndrome type B (mucopolysaccharidosis type IIIB)","volume":"39","author":"Lee-Chen","year":"2002","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.cca.2017.08.017_bb0155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cca.2013.01.009","article-title":"Mucopolysaccharidosis type IIIB mutations in Chinese patients: identification of two novel NAGLU mutations and analysis of two cases involving prenatal diagnosis","volume":"419","author":"Tang","year":"2013","journal-title":"Clin. Chim. Acta"},{"issue":"18","key":"10.1016\/j.cca.2017.08.017_bb0160","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.1073\/pnas.0711491105","article-title":"Structural and mechanistic insight into the basis of mucopolysaccharidosis IIIB","volume":"105","author":"Ficko-Blean","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"23-24","key":"10.1016\/j.cca.2017.08.017_bb0165","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1016\/j.cca.2011.08.032","article-title":"Molecular characterization of MPS IIIA, MPS IIIB and MPS IIIC in Tunisian patients","volume":"412","author":"Ouesleti","year":"2011","journal-title":"Clin. Chim. Acta"},{"issue":"7","key":"10.1016\/j.cca.2017.08.017_bb0170","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10038-005-0258-4","article-title":"Sanfilippo type B syndrome: five patients with an R565P homozygous mutation in the alpha-N-acetylglucosaminidase gene from the Okinawa islands in Japan","volume":"50","author":"Chinen","year":"2005","journal-title":"J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.cca.2017.08.017_bb0175","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1098-1004(1997)10:3<223::AID-HUMU8>3.0.CO;2-J","article-title":"Identification of 31 novel mutations in the N-acetylgalactosamine-6-sulfatase gene reveals excessive allelic heterogeneity among patients with Morquio A syndrome","volume":"10","author":"Bunge","year":"1997","journal-title":"Hum. Mutat."},{"issue":"5","key":"10.1016\/j.cca.2017.08.017_bb0180","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jmb.2012.08.020","article-title":"The structure of human GALNS reveals the molecular basis for mucopolysaccharidosis IV A","volume":"423","author":"Rivera-Colon","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.cca.2017.08.017_bb0185","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cca.2015.08.006","article-title":"Novel missense mutation in the GALNS gene in an affected patient with severe form of mucopolysaccharidosis type IVA","volume":"450","author":"Seyedhassani","year":"2015","journal-title":"Clin. Chim. Acta"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898117303194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898117303194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T05:51:33Z","timestamp":1535435493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898117303194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":37,"alternative-id":["S0009898117303194"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2017.08.017","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical, biochemical and molecular features of Iranian families with mucopolysaccharidosis: A case series","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2017.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}